Industry and public representatives alike can sign up to participate in an open meeting early next month at US FDA headquarters to talk about the fourth device user-fee deal recently struck with the agency.
FDA and industry trade groups announced that a draft MDUFA IV agreement was reached in August. The agreement includes some new review performance goal categories, upgrades to some existing goals,...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?